federal_register: 2020-28069

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2020-28069 Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials; Public Meeting Notice The Food and Drug Administration (FDA, Agency, or we) is announcing a public meeting that will be convened by Duke University's Robert J. Margolis Center for Health Policy and supported by a cooperative agreement with FDA. The meeting, entitled "Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials," is intended to gather industry, patient, clinician, researcher, institutional review board, ethicist, professional society and other stakeholder input on the scientific and ethical issues that surround the inclusion of pregnant women in clinical trials for drug development. 2020-12-21 2020 12 https://www.federalregister.gov/documents/2020/12/21/2020-28069/scientific-and-ethical-considerations-for-the-inclusion-of-pregnant-women-in-clinical-trials-public https://www.govinfo.gov/content/pkg/FR-2020-12-21/pdf/2020-28069.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA, Agency, or we) is announcing a public meeting that will be convened by Duke University's Robert J. Margolis Center for Health Policy and supported by a cooperative agreement with FDA. The meeting, entitled...

Links from other tables